Sherman Prize Honors Excellence in Crohn’s and Colitis
by Sunanda V. Kane, MD, FACG
This week, the recipients of the inaugural Sherman Prize were announced. As a member of the Prize Selection Committee, I am proud to share this news with ...

Jun 24th, 2016 – by ACG News TeamComments Off on “Enter the Biosimilars”: An ACG-CCFA Webinar with Dr. David T. Rubin

ACG and CCFA Co-Hosted an IBD Circle Webinar
Optimizing Medical Therapy in IBD:
Enter the Biosimilars
June 29, 2016
David T. Rubin, MD, FACG
You can listen this webinar with David T. Rubin, MD, FACG who shares insights on how clinicians ...

Oct 8th, 2015 – by ACG News TeamComments Off on A Randomized, Double-Blind, Placebo-Controlled Trial of Ozanimod, an Oral S1P Receptor Modulator, in Moderate to Severe Ulcerative Colitis: Results of the Maintenance Period of the TOUCHSTONE Study

A new guidebook and video is now available from the American College of Gastroenterology to help patients understand that ulcerative colitis (UC) is a treatable condition that can be managed effectively. This valuable resource is designed for ...

Stephen B. Hanauer, MD, FACG
I remain an IBD-ologist and at DDW I tend to focus on advances in our field. So, what did I learn?
IBD causation is not simple or easy (yet). There is a spectrum of complexity between gene and environmental interactions. ...